Tvardi Therapeutics

Biotechnology, Health Care, Pharmaceutical, Service Industry
Founded in 2017-01-01
Houston, Texas, United States
http://www.tvarditherapeutics.com
For Profit

About Tvardi Therapeutics

Tvardi Therapeutics they are focused on the development of orally delivered, small molecule inhibitors of STAT3. They provide medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 81418254 USD
  • Last Funding: 72418254 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Tvardi Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical, Service Industry

Headquarters: Houston, Texas, United States